SPY330.06+1.27 0.39%
DIA268.41+1.69 0.63%
IXIC10,941.17+38.37 0.35%

Jefferies Initiates Coverage On Phathom Pharmaceuticals with Buy Rating, Announces $32 Price Target

Jefferies initiates coverage on Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy rating and a $32 price target.

Benzinga · -

Jefferies initiates coverage on Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy rating and a $32 price target.